市場調查報告書

心房纖維顫動設備的全球市場:2019年∼2025年

Global Atrial Fibrillation Devices Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 888707
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
心房纖維顫動設備的全球市場:2019年∼2025年 Global Atrial Fibrillation Devices Market 2019-2025
出版日期: 2019年07月02日內容資訊: 英文
簡介

本報告提供全球心房纖維顫動設備市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

  • 調查方法與工具
  • 市場分析
    • 各市場區隔
    • 各地區
    • 各利害關係者

第2章 市場概要與考察

  • 報告的範圍
  • 分析師的考察、目前市場趨勢
    • 主要調查結果
    • 推薦事項
    • 結論
  • 規則與法規

第3章 競爭環境

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Abbott Laboratories, Inc.
    • Johnson&Johnson Services,Inc.
    • Boston Scientific Corp.
    • Medtronic PLC
    • Siemens AG

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球心房纖維顫動設備市場:各產品
    • 電生理學導管消融術
    • 電氣生理學診斷導管
    • 電生理學製圖及記錄系統
    • 心臟監測
    • 其他(左心房附屬器(LAA)及封閉設備)
  • 全球心房纖維顫動設備市場:各終端用戶
    • 醫院、診療所
    • 門診外科手術中心(ASC)

第6章 地區分析

  • 北美
    • 南北美洲
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區

第7章 企業概要

  • Abbott Laboratories Inc.
  • AblaCor Medical Corp.
  • AtriCure, Inc.
  • Biomerics, LLC
  • Biotronik, Inc.
  • Boston Scientific Corp.
  • CardioFocus, Inc.
  • CathVision ApS
  • General Electric Co.
  • Integer Holdings Corp.
  • Japan Lifeline Co., Ltd.
  • Johnson & Johnson (Biosense Webster, Inc.)
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Microport Scientific Corp.
  • Millar, Inc.
  • Molecular Devices, LLC
  • Rhythmlink International, LLC
  • Sanofi SA
  • Stryker Corp.
  • Transonic Systems, Inc.
目錄
Product Code: OMR2019751

Global Atrial Fibrillation Devices Market Size, Share & Trends Analysis Report by Product (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology, Mapping and Recording Systems, Cardiac Monitors, and Others), by End-User (Hospitals & Clinics and Ambulatory Surgical Centers), and Forecast, 2019 - 2025

Atrial fibrillation is an irregular heartbeat that leads to an increased risk of stroke and other heart-related diseases. It is one of the most common types of arrhythmias that resulting heart to beat much faster than normal. During atrial fibrillation, the blood pools in the heart that increase the risk of developing a stroke or other heart-related complications. The global atrial fibrillation devices market is expected to exhibit considerable growth during the forecast period. The market growth is attributed to increasing cases of atrial fibrillation coupled with the rising geriatric population, which surges the demand for atrial fibrillation devices for the treatment of disease. In addition, increasing demand for catheter ablation procedures is boosting the growth of the market.

The global atrial fibrillation devices market is segmented on the basis of product (electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology, mapping and recording systems, cardiac monitors, and others) and end-user (hospitals and clinics and ambulatory surgical centers). Among the products, electrophysiology ablation catheters are expected to contribute significantly to the market growth. In addition, the application of atrial fibrillation devices is the highest in hospitals and clinics owing to an increasing proportion of cardiac surgeries performed coupled with the availability of skilled cardiac surgeons in the hospitals.

Geographically, the market report includes the study of four major regions; North America (US, Canada), Europe (Germany, UK, Spain, Italy, France, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and Rest of the World (RoW). Asia-Pacific is expected to witness optimistic growth during the forecast period. Increasing cases of cardiac diseases coupled with the rising geriatric population are one of the major factors spurring the growth of the market in the Asia-Pacific region. Moreover, North America is expected to hold a prominent position in the global market due to the major contribution from the US coupled with the presence of key market players, such as Johnson & Johnson, Abbott Laboratories Inc., and Boston Scientific Corp. in the region.

Further, the global atrial fibrillation market is dominated by some of the leading players that include Abbott Laboratories Inc., Johnson & Johnson, Boston Scientific Corp., Siemens AG, Medtronic PLC, Atricure Inc., Microport Scientific Corp., and Koninklijke Philips N.V. These players with a robust product line and strong financial condition contribute major share in the revenue generation of the global atrial fibrillation market.

Research Methodology

The market study of the global atrial fibrillation devices market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authenticate databases such as the American Heart Association, the World Health Organization (WHO), and others.
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog

The report is intended for healthcare organizations, medical device manufacturers, original equipment manufacturers (OEM), market research firms, investment companies, government societies for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Atrial Fibrillation Devices Market Research and Analysis by Product
  • 2. Global Atrial Fibrillation Devices Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global atrial fibrillation devices market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global atrial fibrillation devices market.
  • Insights about market determinants which are stimulating the global atrial fibrillation devices market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott Laboratories, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Johnson & Johnson Services, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Boston Scientific Corp.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Medtronic PLC
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Siemens AG
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Atrial Fibrillation Devices Market by Products
    • 5.1.1. Electrophysiology Ablation Catheters
    • 5.1.2. Electrophysiology Diagnostic Catheters
    • 5.1.3. Electrophysiology Mapping and Recording Systems
    • 5.1.4. Cardiac Monitors
    • 5.1.5. Others (Left Atrial Appendage (LAA) & Closure Devices)
  • 5.2. Global Atrial Fibrillation Devices Market by End-User
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Ambulatory Surgical Centers (ASC)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. Japan
    • 6.3.3. India
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. AblaCor Medical Corp.
  • 7.3. AtriCure, Inc.
  • 7.4. Biomerics, LLC
  • 7.5. Biotronik, Inc.
  • 7.6. Boston Scientific Corp.
  • 7.7. CardioFocus, Inc.
  • 7.8. CathVision ApS
  • 7.9. General Electric Co.
  • 7.10. Integer Holdings Corp.
  • 7.11. Japan Lifeline Co., Ltd.
  • 7.12. Johnson & Johnson (Biosense Webster, Inc.)
  • 7.13. Koninklijke Philips N.V.
  • 7.14. Medtronic PLC
  • 7.15. Microport Scientific Corp.
  • 7.16. Millar, Inc.
  • 7.17. Molecular Devices, LLC
  • 7.18. Rhythmlink International, LLC
  • 7.19. Sanofi SA
  • 7.20. Stryker Corp.
  • 7.21. Transonic Systems, Inc.

List of Figures

  • 1. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY PRODUCTS, 2018 VS 2025 (%)
  • 2. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 3. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
Back to Top